Origin of histotripsy
The science of histotripsy was developed by leading ultrasound scientists from the University of Michigan as a non-invasive potential alternative to certain surgical procedures.
Translating science to clinical practice
Leading multi-disciplinary clinicians from the University of Wisconsin and the University of Michigan collaborate through ongoing partnerships with HistoSonics to bring histotripsy into everyday clinical practice.
Executive Team
Successful developers of companies and technologies.
Board of Directors
Our Board has deep experience in creating value in medical technology.
Jim Adox
Chairman of the Board (HistoSonics) and Managing Director - Venture Investors, LLC
Mike Blue
President, CEO - HistoSonics
Kadir Kadhiresan, PhD
Vice President - Johnson & Johnson Innovation – JJDC, Inc.
Tom Tefft
Former President - Medtronic Neuromodulation
Gerry Brunk
Managing Director - Lumira Ventures
Erica Rogers
President and CEO - Silk Road Medical
David Hahn, MD
Chief Medical Officer, Varian Interventional Solutions - Varian Medical Systems
Fred Lee Jr., MD
Senior Medical Advisor - HistoSonics
Wen Chen
Partner - Yonjin Venture
Our Investors
We are supported by leading venture capital and healthcare investors who have a history of building great organizations.
Venture Investors Healthfund
Premier provider of seed and early stage venture capital to healthcare companies.
Lumira Ventures
Partners & invests in best-in-class innovative biotherapeutic & medtech entrepreneurs building transformative companies.
Varian Medical Systems
Applying human ingenuity to help you elevate cancer care.
Johnson & Johnson Innovation, JJDC
Investing in and supporting the global entrepreneurial community to solve critical healthcare needs.
Yonjin Venture
Specializes in early and mid-stage life science companies. We are interested in innovative technologies in therapeutics, diagnostics and medical devices.
TGap Ventures
Helps entrepreneurs define, develop, grow, and build value in their businesses, principally in medicine healthcare technology.
Fletcher Spaght Ventures
Investing in promising new ventures in emerging technologies with high growth potential.
Early Stage Partners
Provides early stage venture capital to promising entrepreneurial companies in healthcare technology and other fields..
Hatteras Venture Partners
Building transformational human medicine companies that benefit patients and the professionals who serve them.